ArticleBritish journal of pharmacology2015

The orally active urotensin receptor antagonist, KR36676, attenuates cellular and cardiac hypertrophy.

K S Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.